209 related articles for article (PubMed ID: 21805093)
21. ACTH-Cell Pituitary Adenoma With Signet Ring Cells: A Rare Case Report and Review of The Literature.
Trabzonlu L; Agirlar Trabzonlu T; Gurbuz Y; Ceylan S
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):e13-e16. PubMed ID: 32044887
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
23. [Ectopic pituitary adenoma. Case report and review of literature].
Warczyńska A; Zieliński G; Koziarski A; Podgórski JK
Neurol Neurochir Pol; 2002; 36(6):1185-96. PubMed ID: 12715695
[TBL] [Abstract][Full Text] [Related]
24. Histopathological and physiological characteristics of cultured human ACTH-secreting cells derived from a rapidly growing pituitary adenoma.
Abe T; Tachikawa T; Sasaki A; Taniyama M; Okamura Y; Izumiyama H; Matsumoto K
Brain Tumor Pathol; 2000; 17(3):133-8. PubMed ID: 11310920
[TBL] [Abstract][Full Text] [Related]
25. An ACTH and FSH producing invasive pituitary adenoma with Crooke's hyalinization.
Kamijo K; Sato M; Saito T; Yachi A; Minase T; Noro H; Kawahara T
Pathol Res Pract; 1991 Jun; 187(5):637-41. PubMed ID: 1717963
[TBL] [Abstract][Full Text] [Related]
26. Silent corticotroph adenomas.
Ben-Shlomo A; Cooper O
Pituitary; 2018 Apr; 21(2):183-193. PubMed ID: 29344907
[TBL] [Abstract][Full Text] [Related]
27. Expression of Neuropeptide Y and Its Relationship with Molecular and Morphological Changes in Human Pituitary Adenomas.
Jia R; Li M; Chang B; Chen L; Ma J
Cancer Biother Radiopharm; 2015 Dec; 30(10):411-9. PubMed ID: 26683132
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
[TBL] [Abstract][Full Text] [Related]
29. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
[TBL] [Abstract][Full Text] [Related]
30. Pituitary corticotroph tumour with adrenocortical cells: A distinct clinicopathologic entity with unique morphology and methylation profile.
Hickman RA; Gionco JT; Faust PL; Miller ML; Bruce J; Page-Wilson G; Rosenblum MK; Asa SL
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12754. PubMed ID: 34296770
[TBL] [Abstract][Full Text] [Related]
31. A corticotroph pituitary adenoma as the initial presentation of familial glucocorticoid deficiency.
Benoit I; Drui D; Chaillous L; Dupas B; Mosnier JF; Charbonnel B; Cariou B
Eur J Endocrinol; 2009 Jul; 161(1):195-9. PubMed ID: 19423561
[TBL] [Abstract][Full Text] [Related]
32. ACTH-secreting Crooke cell carcinoma of the pituitary.
Kovács GL; Góth M; Rotondo F; Scheithauer BW; Carlsen E; Saadia A; Hubina E; Kovács L; Szabolcs I; Nagy P; Czirják S; Hanzély Z; Kovács K; Horváth É; Korbonits M
Eur J Clin Invest; 2013 Jan; 43(1):20-6. PubMed ID: 23134557
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology and biomarker profile of pituitary adenohypophysial tumors.
Mete O; Cintosun A; Pressman I; Asa SL
Mod Pathol; 2018 Jun; 31(6):900-909. PubMed ID: 29434339
[TBL] [Abstract][Full Text] [Related]
34. O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas.
Salehi F; Scheithauer BW; Kovacs K; Horvath E; Syro LV; Sharma S; Manoranjan B; Cusimano M
Neurosurgery; 2012 Feb; 70(2):491-6; discussion 496. PubMed ID: 21822153
[TBL] [Abstract][Full Text] [Related]
35. Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia.
Haap M; Gallwitz B; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):289-93. PubMed ID: 19085700
[TBL] [Abstract][Full Text] [Related]
36. Adrenocortical-pituitary hybrid tumor causing Cushing's syndrome.
Hiroi N; Chrousos GP; Kohn B; Lafferty A; Abu-Asab M; Bonat S; White A; Bornstein SR
J Clin Endocrinol Metab; 2001 Jun; 86(6):2631-7. PubMed ID: 11397864
[TBL] [Abstract][Full Text] [Related]
37. The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in 26 tumors.
Trouillas J; Girod C; Sassolas G; Claustrat B
Semin Diagn Pathol; 1986 Feb; 3(1):42-57. PubMed ID: 3112888
[TBL] [Abstract][Full Text] [Related]
38. Triple jeopardy in the pituitary.
Goh KP; Lee HY; Rajasoorya RC
Pituitary; 2008; 11(3):331-6. PubMed ID: 18058238
[TBL] [Abstract][Full Text] [Related]
39. Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas.
Lim JS; Lee MK; Choi E; Hong N; Il Jee S; Kim SH; Lee EJ
Endocrine; 2019 Apr; 64(1):147-156. PubMed ID: 30474823
[TBL] [Abstract][Full Text] [Related]
40. Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.
Annamalai AK; Dean AF; Kandasamy N; Kovacs K; Burton H; Halsall DJ; Shaw AS; Antoun NM; Cheow HK; Kirollos RW; Pickard JD; Simpson HL; Jefferies SJ; Burnet NG; Gurnell M
Pituitary; 2012 Sep; 15(3):276-87. PubMed ID: 22076588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
